Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human t-Plasminogen Activator/tPA His Protein
SDP

Catalog No. NBP25955350
Click to view available options
Quantity:
250 μg
50 μg

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A recombinant protein with a C-Terminal His-tag and corresponding to the amino acids 311-562 of Human t-Plasminogen Activator/tPA The Recombinant Human t-Plasminogen Activator/tPA Protein is derived from Baculovirus. The Recombinant Human t-Plasminogen Activator/tPA Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 0.5mg/mL
For Use With (Application) SDS-PAGE
Formulation Liquid. 50mM MES (pH 5.0) containing 5mM CaCl2, 1mM DTT, 0.5M NaCl, 20% glycerol
Gene ID (Entrez) 5327
Molecular Weight (g/mol) 29.2 kDa
Name Recombinant Human t-Plasminogen Activator/tPA Protein
Purification Method >90%, by SDS-PAGE
Quantity 50 μg
Source Baculovirus
Storage Requirements Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
Regulatory Status RUO
Endotoxin Concentration < 1.0 EU per 1 microgram of protein (determined by LAL method)
Gene Alias Alteplase, DKFZp686I03148, EC 3.4.21, EC 3.4.21.68, plasminogen activator, tissue, plasminogen activator, tissue type, reteplase, tissue plasminogen activator (t-PA), tissue-type plasminogen activator, TPA, T-PA, t-plasminogen activator
Gene Symbol PLAT
Product Type Recombinant Protein
Conjugate Unconjugated
Cross Reactivity Human
Recombinant Recombinant
Show More Show Less

For Research Use Only.

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.